Therapeutic potential and pharmacological activities of Atractylodes lancea (Thunb.) DC.

Nut Koonrungsesomboon, Kesara Na-Bangchang, Juntra Karbwang
Author Information
  1. Nut Koonrungsesomboon: Department of Clinical Product Development, Institute of Tropical Medicine, Nagasaki University, Japan.
  2. Kesara Na-Bangchang: Graduate Program in Bioclinical Sciences, Chulabhorn International College of Medicine, Thammasat University, Thailand.
  3. Juntra Karbwang: Department of Clinical Product Development, Institute of Tropical Medicine, Nagasaki University, Japan. Electronic address: karbwangj@nagasaki-u.ac.jp.

Abstract

The rhizome of Atractylodes lancea (A. lancea) (Thunb.) DC. (AL) is extensively used in Chinese, Thai, and Japanese traditional medicines as crude extracts/decoctions or a component in various herbal formulations. Various pharmacological activities of AL and its major constituents have been demonstrated in vitro, ex vivo, and in animal models. Results from the toxicity studies in animal models suggest safety profile of AL and its active constituents. Despite extensive use with positive impression in many diseases, there has not been a clinical study that can conclusively support its efficacy and safety profile in human. This review comprehensively summarizes current information on the pharmacological activities of AL and their active constituents including anticancer, anti-inflammatory, antimicrobial and antipyretic activities, as well as activities on central nervous, cardiovascular, and gastrointestinal systems.

Keywords

MeSH Term

Animals
Antineoplastic Agents
Atractylodes
Cardiovascular Agents
Cell Line
Gastrointestinal Agents
Humans
Medicine, East Asian Traditional
Mice
Phytotherapy
Plant Extracts
Rats
Rhizome

Chemicals

Antineoplastic Agents
Cardiovascular Agents
Gastrointestinal Agents
Plant Extracts

Word Cloud

Similar Articles

Cited By